Sutton Wealth Advisors Inc. Acorda Therapeutics Inc Transaction History

Sutton Wealth Advisors Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Nov 07, 2023	SELL	$9.12 - $18.12 $22,644 - $44,991	-2,483 Closed	0 $0
Q3 2019 Nov 07, 2023	BUY	$14.34 - $46.14 $18,598 - $59,843	1,297 Added 109.36%	2,483 $7.13 Million
Q2 2019 Nov 06, 2023	BUY	$41.58 - $80.46 $26,777 - $51,816	644 Added 118.82%	1,186 $9.1 Million
Q1 2019 Nov 06, 2023	SELL	$77.58 - $104.82 $13,421 - $18,133	-173 Reduced 24.2%	542 $7.2 Million
Q4 2018 Nov 06, 2023	BUY	$77.64 - $124.86 $13,431 - $21,600	173 Added 31.92%	715 $11.1 Million
Q2 2017 Nov 06, 2023	SELL	N/A	-77 Reduced 12.44%	542 $10.7 Million
Q4 2016 Nov 06, 2023	BUY	N/A	105 Added 20.43%	619 $11.6 Million
Q3 2016 Nov 06, 2023	BUY	N/A	514	514 $10.7 Million

133K

Ticker ACOR
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 24,338,400
Market Cap $6.33M
Description
Acorda Therapeutics, Inc., a biopharmaceutical company, develops and commercializes therapies for neurological disorders in the United States. The company markets Ampyra (dalfampridine), an oral drug to improve walking in patients with multiple sclerosis (MS); and Inbrija for the treatment of OFF periods in Parkinson's disease in Europe. It also...

Get notified when there are updates to the investment portfolio of Sutton Wealth Advisors Inc., based on Form 13F filings with the SEC.

Stay updated on Sutton Wealth Advisors Inc. with notifications on news.